Karyopharm Therapeutics Inc.
KPTI
$1.61
-$0.09-5.03%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 65.11M | 90.85M | 63.74M | 45.88M | 51.70M |
| Total Receivables | 29.87M | 23.36M | 26.18M | 31.88M | 32.93M |
| Inventory | 3.99M | 3.60M | 4.04M | 3.97M | 4.99M |
| Prepaid Expenses | 7.41M | 8.53M | 9.19M | 8.03M | 8.25M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 106.38M | 126.33M | 103.15M | 89.75M | 97.87M |
|
|
|||||
| Total Current Assets | 106.38M | 126.33M | 103.15M | 89.75M | 97.87M |
| Net Property, Plant & Equipment | 4.35M | 4.50M | 4.65M | 4.80M | 5.33M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 585.00K | 584.00K | 618.00K | 1.68M | 1.68M |
| Total Assets | 111.32M | 131.42M | 108.42M | 96.23M | 104.88M |
|
|
|||||
| Total Accounts Payable | 7.66M | 4.28M | 4.00M | 5.39M | 2.60M |
| Total Accrued Expenses | 78.80M | 76.30M | 64.50M | 66.33M | 62.93M |
| Short-term Debt | -- | -- | -- | 250.00K | 24.48M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 41.38M | 33.25M | 21.98M | 13.42M | 7.63M |
| Total Finance Division Other Current Liabilities | 6.39M | 3.47M | 1.58M | 1.77M | 1.57M |
| Total Other Current Liabilities | 6.39M | 3.47M | 1.58M | 1.77M | 1.57M |
| Total Current Liabilities | 134.23M | 117.30M | 92.06M | 87.16M | 99.22M |
|
|
|||||
| Total Current Liabilities | 134.23M | 117.30M | 92.06M | 87.16M | 99.22M |
| Long-Term Debt | 281.97M | 264.49M | 278.22M | 250.24M | 225.75M |
| Short-term Debt | -- | -- | -- | 250.00K | 24.48M |
| Capital Leases | 5.18M | 5.47M | 5.74M | 6.01M | 6.25M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 20.10M | 9.80M | 25.32M | 22.08M | 12.59M |
| Total Liabilities | 441.49M | 397.06M | 401.34M | 365.49M | 343.81M |
|
|
|||||
| Common Stock & APIC | 1.52B | 1.52B | 1.47B | 1.39B | 1.39B |
| Retained Earnings | -1.85B | -1.78B | -1.76B | -1.66B | -1.62B |
| Treasury Stock & Other | 41.00K | 43.00K | 71.00K | -259.00K | -251.00K |
| Total Common Equity | -330.17M | -265.65M | -292.93M | -269.26M | -238.93M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -330.17M | -265.65M | -292.93M | -269.26M | -238.93M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -330.17M | -265.65M | -292.93M | -269.26M | -238.93M |
|
|
|||||